Stay updated on Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.

Latest updates to the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page
- Check4 days agoChange DetectedThe footer's displayed ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1; the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now returns a 403 Forbidden error instead of the study details, indicating restricted access; a Home link is displayed on the error screen and the normal content is not reachable.SummaryDifference23%

- Check25 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, indicating a small platform update rather than changes to study information or layout.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's Revision tag was updated from v3.6.5 to v3.6.6, indicating a minor backend revision.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, representing a minor update to the page's revision history. No changes to the study details or core content are indicated.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded NIH-required analyses for adverse events by sex and by race for mothers and infants, and updated timeframes (e.g., From birth through Week 50 postpartum) and measure descriptions to reflect these analyses.SummaryDifference1%

Stay in the know with updates to Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.